COMMANDS Full Analysis
COMMANDS: Full Analysis of Phase III Trial of Luspatercept vs Epoetin alfa for ESA-Naive, Transfusion-Dependent, Lower-Risk MDS

Released: December 10, 2023

Activity

Progress
1
Course Completed